Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of High Dose Inhaled Nitric Oxide in Intubated Patients Admitted With COVID-19

NCT04383002 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04383002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of High Dose Inhaled Nitric Oxide in Intubated Patients Admitted With COVID-19
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
September 2, 2020
Completion date
June 11, 2021
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19